Big Gain For Capricor Therapeutics, Inc.
Wed, Apr 29, 2020 at 05:30 PM
Capricor Therapeutics, Inc. (CAPR:NASDAQ) shot up at $8.5, a gain of 252.7%. On Tue 28 Apr 20, CAPR:NASDAQ hit a New 2-Week Intraday High of $2.65. The stock appeared on our News Catalysts scanner on Wed 29 Apr 20 at 12:10 PM in the 'BIOTECH' category. From Tue 14 Apr 20, the stock recorded 70.00% Up Days and 63.64% Green Days
About Capricor Therapeutics, Inc. (CAPR:NASDAQ)
Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure.
Top 10 Gainers:
- Capricor Therapeutics, Inc. (CAPR:NASDAQ), 252.7%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 160.18%
- Penn Virginia Corporation (PVAC:NASDAQ), 79.37%
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 78.01%
- SM Energy Company (SM:NYSE), 74.6%
- Mohawk Group Holdings, Inc. (MWK:NASDAQ), 54.55%
- InnerWorkings, Inc. (INWK:NASDAQ), 49.3%
- R. R. Donnelley & Sons Company (RRD:NYSE), 45.6%
- Vislink Technologies, Inc. (VISL:NASDAQ), 44.68%
- Chimerix, Inc. (CMRX:NASDAQ), 42.38%